Boston University
Type 1 diabetes misdiagnosis in a safety-net healthcare setting: prevalence, inequities, and determinants
Abstract
dc:description.abstractBACKGROUND: Approximately 1.2 million Americans are diagnosed with diabetes every year, with type 1 diabetes (T1D) accounting for 5-10% of diabetes diagnoses. Recent research suggests that approximately 25% of those diagnosed with T1D have been previously misdiagnosed with type 2 diabetes (T2D). Studies on T1D misdiagnosis are limited; it is unknown if these rates vary across populations, and the factors that contribute to misdiagnosis are unclear. However, the risks of harm due to delayed T1D diagnosis or misdiagnosis make it imperative to understand how to identify and understand this prevalent occurrence. OBJECTIVES: This study was designed to determine the prevalence of T1D misdiagnosis in a diverse, safety-net population and to identify factors that are associated with misdiagnosis, such as belonging to a minoritized population. METHODS: This cross-sectional survey-based study was conducted at Boston Medical Center (BMC). Recruitment occurred over a three-month period in the adult outpatient endocrinology clinic. Subjects included adults with T1D who had been seen in the clinic within the last year and had a preferred language of English or Spanish. The survey examined the sociodemographic, medical history, and health experience of all participants. Logistic regression models were used to analyze the odds ratios (ORs) of possible contributing factors to T1D misdiagnosis. Akaike Information Criterion (AIC) was used to select potential predictors. RESULTS: A total of 132 individuals completed the survey. Of the 132 participants, 38 (28.8%) were previously misdiagnosed; 29 participants as T2D and 9 as another condition. The median age of participants was 41 years old (Interquartile range [IQR] 21.5, [Q1-Q3] 32-53.5), 49% of participants were male and 47% were female, with the remaining participants identifying as gender non-conforming or transgender. Out of all participants, 69 (52.3%) identified as White, 27 (20.5%) identified as Black, 25 (18.9%) as Hispanic, and 11 (8.3%) as Other. Data suggests that participants with higher odds of misdiagnosis identified as female (OR: 1.89; 95% CI, 0.88-4.09), were diagnosed with T1D between 19-34 years of age (OR: 3.59; 95% CI, 1.34-9.60) or 35-64 years of age (OR: 5.86; 95% CI, 1.84 – 18.65), identified as Black (OR: 1.68; 95% CI, 0.67 – 4.26), were prescribed a medication other than insulin (OR: 8.53; 95% CI, 3.50-20.78), or had a family history of prediabetes (OR: 2.20; 95% CI, 0.94-5.10). The factors that had the strongest predictive ability for misdiagnosis were age at T1D diagnosis and sex. CONCLUSIONS: The study demonstrated that there multiple possible factors associated with T1D misdiagnosis, including observed racial inequities in the prevalence of T1D misdiagnosis. The study demonstrates a significant need for further research on contributors to racial inequities in T1D misdiagnosis and identification of strategies to improve correct and timely diagnosis.
Degree
thesis:*- Name thesis:degree_name
- Master of Science
- Level thesis:degree_level
- masters
- Discipline thesis:degree_discipline
- Nutrition and Metabolism
- Grantor
- Boston University
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Sanchez, Zoe Dare Waldo
- Advisors dc:contributor.advisor
-
- Fantasia, Kathryn
- Wolpert, Howard
- ORCID dc:identifier.orcid
Subjects
dc:subject × 5Rights
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/53207